Effect of inhaled low molecular weight heparin on methacholine-induced bronchoconstriction

International Journal of Clinical Pharmacology and Therapeutics

Volumn 38, Issue 9, 2000, Pages 446-451

  Ceyhan, B B ^a   Celikel, T ^a  

^a MARMARA UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

Author keywords

Heparin; Low molecular weight heparin; Methacholine induced bronchoconstriction

Indexed keywords

ENOKSAPARIN; ENOXAPARIN; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; METHACHOLINE; PLACEBO;

ADULT; AGED; ARTICLE; ASTHMA; BRONCHOSPASM; BRONCHUS HYPERREACTIVITY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DRUG BIOAVAILABILITY; DRUG MECHANISM; FEMALE; FORCED EXPIRATORY VOLUME; HEPARINIZATION; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; PATHOGENESIS; PROVOCATION TEST; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE;

EID: 0033811380     PISSN: 09461965     EISSN: None     Source Type: Journal    
DOI: 10.5414/CPP38446     Document Type: Article

References (40)

1. Effects of inhaled heparin on immunologic and non-immunologic bronchoconstrictor responses in sheep
2. Preventing bronchoconstriction in exercise-induced asthma with inhaled heparin
3. Inhibition of antigen-induced airway and cutaneous responses by heparin: A pharmacodynamic study
4. Inhibition of antigen-induced acute bronchoconstriction, airway hyperresponsiveness, mast cell degranulation by a non-coagulant heparin
5. Prevention of exercise-induced bronchoconstriction by inhaled low molecular weight heparin
6. Comparative pharmocokinetics of a low molecular weight heparin and unfractioned heparin after intravenous and subcutaneous administration
7. Basic fibroblast growth factor binds to subendothelial extracellular matrix and is released by heparitinase and heparin-like molecules
8. Inhaled (99m)TC-heparin in lung deposition and clearance
9. Characterization of heparin aerosols generated in jet and ultrasonic nebulizers
10. The multiple complexes formed by the interaction of platelet factor 4 with heparin
11. Heparin inhibits the immediate response to antigen in the skin and lungs of allergic subjects
12. Effect of inhaled heparin on methacholine-induced bronchial hyperreactivity
13. Cationic proteins induce airway hyperresponsiveness dependent on charge interactions
14. Effect of inhaled heparin on allergen-induced early and late asthmatic responses in patients with atopic asthma
15. Inhibition of complement-dependent experimental inflammation in human skin by different heparin fractions
16. The antithrombotic activity and pharmacokinetics of enoxaparine, a low molecular weight heparin, in humans given single subcutaneous doses of 20 to 80 mg
17. Function of pulmonary M2 receptors in antigen-challenged guinea pigs is restored by heparin and poly-L-glutamate
18. Time course of the protective effect of inhaled heparin on exercise-induced asthma
19. Heparin, dextran, and tryptan blue allosterically modulate M2 muscarinic receptor-binding properties and interfere with receptor-mediated inhibition of adenylate cyclase
20. Competitive, reversible, and potent antagonism of inositol 1,4,5-triphosphate-activated calcium release by heparin
21. Airway smooth muscle cell proliferation characterization of subpopulations by sensitivity to heparin inhibition
22. Effect of ganglionic blockade on bronchial reactivity in atopic subjects
23. Heparin and low molecular weight heparin block the effects of poly-L-lysine and depress bronchial responsiveness
24. Heparin and PGE2 inhibit DNA synthesis in human airway smooth muscle cells in culture
25. Effect of pretreatment with heparin on pulmonary and cutaneous response
26. Inhibition of airway smooth muscle proliferation by heparin, low molecular weight heparin and heparin sulphate
27. Inhibition of serum-induced proliferation of bovine tracheal smooth muscle cells in culture by heparin and related glycosaminoglycans
28. Inhibition of T lymphocyte heparinase by heparin prevents T cell migration and T-cell-mediated immunity
29. Immunologic mast cell-mediated responses and histamine release are attenuated by heparin
30. Inhibitory effect of low molecular weight heparin on bronchoconstriction in ovalbumin-sensitized guinea pigs after antigen exposure
31. Inhibition of allergic responses by low molecular weight heparins (LMWH): Molecular weight dependence
32. A muscarinic agonist inhibits reflex bronchoconstriction in normal but not in asthmatic subjects
33. Inhibition of antigen-induced airway hyperresponsiveness by ultralow molecular weight heparin
34. Time course of changes in adenosine 5'-monophosphate airway responsiveness with inhaled heparin in allergic asthma
35. Heparin prevents vascular smooth muscle cell proliferation through the G1 phase of the cell cycle
36. Cholinergic contraction of the guinea-pig lung strip is mediated by muscarinic M2-1ike receptors
37. Regulation of tryptase from human lung mast cells by heparin. Stabilization of the active tetramer
38. A single dose of low molecular weight heparin one week before allergen challenge prevented the increase of NO and TNF-α as good as once daily dexamethasone in alveolar macrophages from asthmatic rat model
39. Heparin in inflammation, potential therapeutic applications beyond anticoagulation
40. Muscarinic signaling pathway for calcium release and calcium-activated chloride current in smooth muscle